Skip to main content

Table 3 Results of basic analysis for all 11 screening strategies: average costs per admission and cost savings (net benefits) in comparison to strategy “no screening”

From: Impact of different diagnostic technologies for MRSA admission screening in hospitals – a decision tree analysis

Screening strategy

Average cost per admission

Cost-saving to "no screening"a

PoC (target)

468.14 €

−14.98 €

PCR (target, no isolation)

469.30 €

−13.82 €

PCR (target, isolation)

469.80 €

−13.32 €

Culture (target, no isolation)

501.66 €

18.54 €

Culture (target, isolation)

506.90 €

23.78 €

No screening

483.12 €

0.00 €

PoC (universal)

478.18 €

−4.94 €

PCR (universal, no isolation)

478.75 €

−4.37 €

PCR (universal, isolation)

500.07 €

16.95 €

Culture (universal, no isolation)

741.36 €

258.24 €

Culture (universal, isolation)

925.93 €

442.81 €

  1. aA negative value indicates a positive net benefit